Linda Rossi
Overview
Explore the profile of Linda Rossi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Traversa D, Morelli S, Di Cesare A, Astuti C, Barlaam A, Colombo M, et al.
Animals (Basel)
. 2025 Jan;
15(2.
PMID: 39858171
and are major parasitic nematodes of dogs. Many environmental and phenological changes have recently modified their geographic patterns in many countries; thus, this study has updated the distribution of and...
2.
Jongen C, Heemsbergen W, Incrocci L, Heijmen B, Rossi L
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766106
Background/objectives: Extracting spatial features (texture analysis) from dose distributions (dosiomics) for outcome prediction is a rapidly evolving field in radiotherapy. To account for fraction size differences, the biological effective dose...
3.
van Genderingen J, Nguyen D, Knuth F, Nomer H, Incrocci L, Sharfo A, et al.
Radiother Oncol
. 2024 Dec;
203():110662.
PMID: 39647528
Background And Purpose: Fast, high-quality deep learning (DL) prediction of patient-specific 3D dose distributions can enable instantaneous treatment planning (IP), in which the treating physician can evaluate the dose and...
4.
Nomer H, Knuth F, van Genderingen J, Nguyen D, Sattler M, Zolnay A, et al.
Phys Med Biol
. 2024 Nov;
69(22).
PMID: 39530440
. Intensity modulated proton therapy (IMPT) is susceptible to uncertainties in patient setup and proton range. Robust optimization is employed in IMPT treatment planning to ensure sufficient coverage of the...
5.
Straathof R, van Vliet-Perez S, Kolkman-Deurloo I, Wauben L, Nout R, Heijmen B, et al.
Phys Med Biol
. 2024 Oct;
69(23).
PMID: 39447602
Patient-tailored intracavitary/interstitial (IC/IS) brachytherapy (BT) applicators may increase dose conformity in cervical cancer patients. Current configuration planning methods in these custom applicators rely on manual specification or a small set...
6.
Elhani I, Hentgen V, Quartier P, Bader-Meunier B, Kone-Paut I, Neven B, et al.
J Clin Rheumatol
. 2024 Aug;
30(7):297-299.
PMID: 39186594
Background: Transitioning from pediatric to adult care is a critical step for individuals with autoinflammatory diseases, requiring effective programs to ensure continuity of care and disease management. Despite various recommendations,...
7.
Sealing Wax and Bottles in Bags-A Paradigm Shift in Refined Olive Oil Packaging: Preliminary Results
Macaluso M, Mercanti N, Scappaticci G, Lannocca E, Rossi L, Guidi L, et al.
Foods
. 2023 Nov;
12(22).
PMID: 38002218
Generally, olive oil possesses natural protection against oxidation due to antioxidant compounds such as phenols and tocopherols. However, in the case of refined olive oil, the refining process unavoidably reduces...
8.
Fjellanger K, Hordnes M, Sandvik I, Sulen T, Heijmen B, Breedveld S, et al.
Acta Oncol
. 2023 Aug;
62(10):1194-1200.
PMID: 37589124
Background: Knowledge-based planning (KBP) is a method for automated radiotherapy treatment planning where appropriate optimization objectives for new patients are predicted based on a library of training plans. KBP can...
9.
Rossi L, Breedveld S, Heijmen B
Phys Med Biol
. 2023 Jul;
68(17).
PMID: 37524087
. In conventional radiotherapy, a single treatment plan is generated pre-treatment, and delivered in daily fractions. In this study, we propose to generate different treatment plans for all fractions ('Per-fraction'...
10.
Fiandra C, Cattani F, Leonardi M, Comi S, Zara S, Rossi L, et al.
Adv Radiat Oncol
. 2023 Jul;
8(5):101228.
PMID: 37405256
Purpose: The objective of this work was to investigate the ability of machine learning models to use treatment plan dosimetry for prediction of clinician approval of treatment plans (no further...